Gilder Gagnon Howe & Co’s Entero Therapeutics ENTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
Sell
-4
Closed -$926K 303
2019
Q2
$926K Hold
4
0.01% 228
2019
Q1
$1.31M Hold
4
0.01% 210
2018
Q4
$650K Hold
4
0.01% 216
2018
Q3
$1.43M Hold
4
0.01% 220
2018
Q2
$1.78M Buy
+4
New +$1.78M 0.02% 208